WO2007031883A3 - Composition contenant au moins un derive d'acide naphtoique et au moins un compose de type polymere de polyurethane ou des derives de ce compose, procedes de fabrication et utilisations de cette composition - Google Patents

Composition contenant au moins un derive d'acide naphtoique et au moins un compose de type polymere de polyurethane ou des derives de ce compose, procedes de fabrication et utilisations de cette composition Download PDF

Info

Publication number
WO2007031883A3
WO2007031883A3 PCT/IB2006/003852 IB2006003852W WO2007031883A3 WO 2007031883 A3 WO2007031883 A3 WO 2007031883A3 IB 2006003852 W IB2006003852 W IB 2006003852W WO 2007031883 A3 WO2007031883 A3 WO 2007031883A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
acid derivative
naphthoic acid
derivatives
compound
Prior art date
Application number
PCT/IB2006/003852
Other languages
English (en)
Other versions
WO2007031883A2 (fr
Inventor
Claire Mallard
Eve Ferrara
Original Assignee
Galderma Res & Dev
Claire Mallard
Eve Ferrara
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0509493A external-priority patent/FR2890861B1/fr
Priority to KR1020087006011A priority Critical patent/KR101358490B1/ko
Priority to JP2008530661A priority patent/JP5074401B2/ja
Priority to EP06831837A priority patent/EP1933827A2/fr
Priority to BRPI0617045A priority patent/BRPI0617045B8/pt
Priority to AU2006290364A priority patent/AU2006290364B2/en
Application filed by Galderma Res & Dev, Claire Mallard, Eve Ferrara filed Critical Galderma Res & Dev
Priority to MX2008003422A priority patent/MX2008003422A/es
Priority to CA002622468A priority patent/CA2622468A1/fr
Publication of WO2007031883A2 publication Critical patent/WO2007031883A2/fr
Publication of WO2007031883A3 publication Critical patent/WO2007031883A3/fr
Priority to US12/076,169 priority patent/US7998467B2/en
Priority to US13/171,872 priority patent/US8435502B2/en
Priority to US13/889,163 priority patent/US8709392B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87—Polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)

Abstract

L'invention concerne une composition à application topique, contenant, dans un fluide physiologiquement acceptable, au moins un dérivé d'acide naphtoïque et au moins un composé de type polymère de polyuréthane ou des dérivés de ce composé. La composition selon l'invention est caractérisée en ce que le dérivé d'acide naphtoïque se présente sous forme dispersée dans la composition. La composition selon l'invention est particulièrement destinée aux domaines pharmaceutiques et cosmétiques humains.
PCT/IB2006/003852 2005-09-16 2006-09-15 Composition contenant au moins un derive d'acide naphtoique et au moins un compose de type polymere de polyurethane ou des derives de ce compose, procedes de fabrication et utilisations de cette composition WO2007031883A2 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
CA002622468A CA2622468A1 (fr) 2005-09-16 2006-09-15 Composition contenant au moins un derive d'acide naphtoique et au moins un compose de type polymere de polyurethane ou des derives de ce compose, procedes de fabrication et utilisations de cette composition
JP2008530661A JP5074401B2 (ja) 2005-09-16 2006-09-15 少なくとも１つのナフトエ酸誘導体および少なくとも１つのポリウレタンポリマータイプの化合物またはその誘導体を含む組成物、その調製方法、およびその使用
EP06831837A EP1933827A2 (fr) 2005-09-16 2006-09-15 Composition contenant au moins un derive d'acide naphtoique et au moins un compose de type polymere de polyurethane ou des derives de ce compose, procedes de fabrication et utilisations de cette composition
BRPI0617045A BRPI0617045B8 (pt) 2005-09-16 2006-09-15 composição, processo para preparar uma composição, uso de uma composição e uso cosmético de uma composição
AU2006290364A AU2006290364B2 (en) 2005-09-16 2006-09-15 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof
KR1020087006011A KR101358490B1 (ko) 2005-09-16 2006-09-15 하나 이상의 나프토산 유도체 및 하나 이상의 폴리우레탄중합체 유형 화합물 또는 이의 유도체를 함유하는 조성물,이의 제조 방법 및 이의 용도
MX2008003422A MX2008003422A (es) 2005-09-16 2006-09-15 Composiciones que comprenden al menos un derivado de acido naftoico y al menos un compuesto de tipo polimero de poliuretano o derivados del mismo, procesos de preparacion y composiciones que comprenden al menos un derivado de acido naftoico y al meno
US12/076,169 US7998467B2 (en) 2005-09-16 2008-03-14 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers
US13/171,872 US8435502B2 (en) 2005-09-16 2011-06-29 Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers
US13/889,163 US8709392B2 (en) 2005-09-16 2013-05-07 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0509493 2005-09-16
FR0509493A FR2890861B1 (fr) 2005-09-16 2005-09-16 Compositions comprenant au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethanes ou des derives de celui-ci, leurs procede de preparation, et leur utilisation
US72527905P 2005-10-12 2005-10-12
US60/725,279 2005-10-12

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/076,169 Continuation US7998467B2 (en) 2005-09-16 2008-03-14 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers

Publications (2)

Publication Number Publication Date
WO2007031883A2 WO2007031883A2 (fr) 2007-03-22
WO2007031883A3 true WO2007031883A3 (fr) 2007-09-13

Family

ID=37865321

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/003852 WO2007031883A2 (fr) 2005-09-16 2006-09-15 Composition contenant au moins un derive d'acide naphtoique et au moins un compose de type polymere de polyurethane ou des derives de ce compose, procedes de fabrication et utilisations de cette composition

Country Status (7)

Country Link
EP (1) EP1933827A2 (fr)
JP (2) JP5074401B2 (fr)
AU (1) AU2006290364B2 (fr)
CA (1) CA2622468A1 (fr)
MX (1) MX2008003422A (fr)
RU (1) RU2421216C2 (fr)
WO (1) WO2007031883A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8936800B2 (en) 2001-12-21 2015-01-20 Galderma Research & Development Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916975B1 (fr) * 2007-06-11 2009-09-04 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
FR2916966B1 (fr) * 2007-06-11 2011-01-14 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
AR067470A1 (es) 2007-07-06 2009-10-14 Galderma Res & Dev Composiciones para aplicacion topica para el tratamiento de desordenes de queratina
EP2065032A1 (fr) * 2007-11-27 2009-06-03 Galderma Research & Development Procédé pour la production de gels d'adapalène
KR101538187B1 (ko) * 2007-11-30 2015-07-22 갈데르마 리써어치 앤드 디벨로프먼트 하나 이상의 나프토산 유도체, 과산화 벤조일 및 하나 이상의 필름-형성제를 함유하는 조성물
EP3045171A1 (fr) 2009-06-24 2016-07-20 Strategic Science & Technologies, LLC Composition topique
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
JP5521190B2 (ja) * 2009-10-01 2014-06-11 国立大学法人東京工業大学 コラーゲン組成物及びその製造方法
US20130203850A1 (en) * 2010-04-29 2013-08-08 Galderma Research & Development Method for treating scars with adapalene 0.3%
CN114668851A (zh) 2010-12-29 2022-06-28 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
WO2013131969A2 (fr) * 2012-03-09 2013-09-12 Bayer Materialscience Llc Effet de la substance filmogène en polyuréthane sur l'efficacité d'un traitement de l'acné
JPWO2019240290A1 (ja) * 2018-06-16 2021-06-24 ロート製薬株式会社 外用組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0299758A2 (fr) * 1987-07-16 1989-01-18 The Regents Of The University Of California Compositions augmentant la pénétration cutanée d'agents pharmaceutiquement actifs
JPH061851A (ja) * 1992-06-19 1994-01-11 Toyo Ink Mfg Co Ltd 顔料組成物および水性顔料分散体
US6358541B1 (en) * 2000-05-03 2002-03-19 David S. Goodman Topical preparation for the treatment of hair loss
WO2003075908A1 (fr) * 2002-03-12 2003-09-18 Galderma Research & Development, S.N.C. Emploi d'adapalene pour le traitement de troubles dermatologiques

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0299758A2 (fr) * 1987-07-16 1989-01-18 The Regents Of The University Of California Compositions augmentant la pénétration cutanée d'agents pharmaceutiquement actifs
JPH061851A (ja) * 1992-06-19 1994-01-11 Toyo Ink Mfg Co Ltd 顔料組成物および水性顔料分散体
US6358541B1 (en) * 2000-05-03 2002-03-19 David S. Goodman Topical preparation for the treatment of hair loss
US20020155180A1 (en) * 2000-05-03 2002-10-24 Goodman David S. Topical preparation for treating acne and hirsutism
WO2003075908A1 (fr) * 2002-03-12 2003-09-18 Galderma Research & Development, S.N.C. Emploi d'adapalene pour le traitement de troubles dermatologiques

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199406, Derwent World Patents Index; Class A60, AN 1994-045515, XP002261340 *
KANG SEWON ET AL: "Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial.", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. JUL 2003, vol. 49, no. 1, July 2003 (2003-07-01), pages 83 - 90, XP002376857, ISSN: 0190-9622 *
WOLF J E: "An update of recent clinical trials examining adapalene and acne", JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 2001 UNITED KINGDOM, vol. 15, no. SUPPL. 3, 2001, pages 23 - 29, XP002382359, ISSN: 0926-9959 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8936800B2 (en) 2001-12-21 2015-01-20 Galderma Research & Development Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt

Also Published As

Publication number Publication date
CA2622468A1 (fr) 2007-03-22
AU2006290364B2 (en) 2012-07-05
RU2421216C2 (ru) 2011-06-20
MX2008003422A (es) 2008-03-27
EP1933827A2 (fr) 2008-06-25
JP2009508843A (ja) 2009-03-05
RU2008114840A (ru) 2009-10-27
JP2012184258A (ja) 2012-09-27
WO2007031883A2 (fr) 2007-03-22
JP5074401B2 (ja) 2012-11-14
AU2006290364A1 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
WO2007031883A3 (fr) Composition contenant au moins un derive d'acide naphtoique et au moins un compose de type polymere de polyurethane ou des derives de ce compose, procedes de fabrication et utilisations de cette composition
WO2009077693A3 (fr) Compositions comprenant au moins un derive de l'acide naphtoique, du peroxyde de benzoyle et au moins un agent filmogene
WO2006099941A8 (fr) 8-n-benzimidazoles a substitution aminocarbonyle, leur procede de production, et leur utilisation en tant que medicaments
WO2009074735A8 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2010072958A3 (fr) Composition pharmaceutique topique comprenant un principe actif sensible a l'eau
WO2008139122A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2011148328A3 (fr) Procédé cosmétique pour le maquillage et/ou le soin de la peau et/ou des lèvres
WO2007129270A3 (fr) Nouvelles compositions cosmétiques contenant au moins un peptide doté d'au moins un cycle aromatique immobilisé
WO2008034764A3 (fr) Préparations cosmétiques à base de polymère gravé moléculairement
WO2006119283A3 (fr) Compositions anti-odeurs et utilisation therapeutique associee
MX2009005308A (es) Composiciones que comprenden peroxido de benzoilo, al menos un derivado del acido naftoico y al menos un compuesto del tipo polimeros de poliuretano o derivados de estos y sus usos.
WO2008015249A3 (fr) Composition cosmétique ou pharmaceutique d'acide hyaluronique
WO2006002909A3 (fr) Compositions pharmaceutiques derivees de sphingolipides
WO2008037380A3 (fr) Mélanges d'alkylbenzoates
WO2007132134A3 (fr) Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations
WO2006042661A3 (fr) Oligopeptides et utilisations
WO2011039444A3 (fr) Composition, utilisation et procédé de conservation
IL201730A (en) History 1h - Benzaimidazole – 2 – Il – Profile – Methyl – Amino – Ethyl – 5 – Aryl – Bicyclo [2.2.2] Oct – 5 – Ann – 2 – All, Pharmaceutical preparations containing them and their use in the preparation of drugs
WO2008139123A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2007075255A3 (fr) Composition de gomme mastic utilisable en tant que complement alimentaire pour les humains et les animaux
WO2007077318A3 (fr) Utilisation d'un extrait peptidique de riz en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
PL1868631T3 (pl) Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej
WO2008148966A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
DE602007010945D1 (de) Zusammensetzung mit mindestens einem c-glycosid-derivat und mindestens einer hyaluronsäure sowie ihre kosmetische anwendung
WO2007009989A3 (fr) COMPOSITION COMPRENANT UNE DISPERSION LIPOSOMALE DE NANOPARTICULES DE SIO2 ET UN DERIVE D'ETHER DE GLUCANE A LIAISON ß-1,3

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2006831837

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006290364

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: MX/a/2008/003422

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1020087006011

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2622468

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2008530661

Country of ref document: JP

Ref document number: 200680033965.4

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2239/DELNP/2008

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2006290364

Country of ref document: AU

Date of ref document: 20060915

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006290364

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2008114840

Country of ref document: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06831837

Country of ref document: EP

Kind code of ref document: A2

WWP Wipo information: published in national office

Ref document number: 2006831837

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0617045

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080314